Aggregate & Fragment Analysis

Protein and mAb Separations
HPLC columns to achieve accuracy and speed when analyzing peptides, proteins, monoclonal antibodies and antibody drug conjugates
READ MORE >
N-Glycan Sample Preparation and Analysis
A full line of tools to streamline your glycan analysis, including sample preparation kits, glycobiology standards, enzymes, and glycan columns
READ MORE >
Oligonucleotide Separations
HPLC columns for robust resolution and reproducible analysis and purification of oligonucleotides, from siRNA through mRNA
READ MORE >
Adeno-Associated Virus Characterization
Reproducibly and efficiently identify intact AAV capsids, the ratio of full to empty, or measurement of aggregates
READ MORE >

Inert, Robust Columns for Size Exclusion Chromatography

Agilent offers size exclusion chromatography (SEC) HPLC columns in a wide variety of pore sizes to address every aggregate or fragment analysis challenge. AdvanceBio SEC columns featuring unique hydrophilic bonding for minimal secondary interactions are available in 2.7 µm and 1.9 µm particle sizes, for high throughput, high resolution separations.

Agilent Wins Multiple 2022 Scientists' Choice Awards

Agilent received two 2022 Scientists’ Choice Awards for Drug Discovery & Development, Virtual Event of the Year and Innovative Content of the Year, at the SLAS2022 International Conference & Exhibition on February 7th, 2022. The Scientists’ Choice Awards recognize the world’s most innovative and effective analytical science technologies and communications.

Agilent Wins Multiple 2022 Scientists' Choice Awards
15 Feb 2022

The Importance of Glycan Analysis and Characterization for Biopharma

Professor Michael Butler, head of the National Institute for Bioprocessing Research and Training (NIBRT) Cell Technology Group (CTG), explains that the characterisation and analysis of glycans is important for the biopharma sector as it can help in the development of therapeutic agents, such as monoclonal antibodies and other recombinant proteins. These are used in therapies in a range of serious conditions including cancer, inflammatory diseases, and cardiovascular diseases. The mechanism of action depends upon their strong affinity to molecular targets associated with disease.

Drug Discovery World (DDW)
10 Oct 2022

0 product selected.

Clear All

Aggregate & Fragment Analysis

Inert, Robust Columns for Size Exclusion Chromatography